[ad_1]
Anheuser-Busch InBev reported booming profits on Thursday thanks to cost cutting even as the brewer still wrestles with a consumer boycott of Bud Light in the U.S.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...